Elevance Health (ELV) Current Deferred Revenue (2009 - 2026)

Elevance Health (ELV) has 18 years of Current Deferred Revenue data on file, last reported at $1.6 billion in Q2 2026.

• On a quarterly basis, Current Deferred Revenue rose 5.06% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 5.06% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 0.99% from the prior year.
• Current Deferred Revenue for Q2 2026 stood at $1.6 billion, down from $1.8 billion in the prior quarter.
• Over the last five years, Current Deferred Revenue for ELV reached as high as $4.5 billion in Q2 2023 and fell as low as $971.0 million in Q2 2022.
• Historically, Current Deferred Revenue has averaged $2.1 billion across 5 years, with a median of $1.6 billion in 2025.
• Across the five-year window, Current Deferred Revenue jumped 359.11% in 2023 and slumped 66.78% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $1.1 billion in 2022, then increased by 26.08% to $1.4 billion in 2023, then climbed by 7.56% to $1.5 billion in 2024, then declined by 0.99% to $1.5 billion in 2025, then gained by 9.85% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $1.6 billion in Q2 2026, $1.8 billion in Q1 2026, and $1.5 billion in Q4 2025.